A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma.
de Souza
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant / Q000191:economics; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003362:Cost-Benefit Analysis; D005472:Fluorouracil / Q000008:administration & dosage* / Q000191:economics; D006801:Humans; D007978:Levamisole / Q000008:administration & dosage* / Q000191:economics; D009367:Neoplasm Staging; D011788:Quality of Life; D026712:Value of Life
D007978:Levamisole; D005472:Fluorouracil